Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Zhonghua Jie He He Hu Xi Za Zhi ; 45(8): 762-767, 2022 Aug 12.
Article in Chinese | MEDLINE | ID: mdl-35927046

ABSTRACT

Objective: A questionnaire survey was conducted on the clinical practice of tracheostomy decannulation among medical staff in medical institutions at all levels across the country. Methods: The questionnaire was determined by literature review and expert consultation to investigate the clinical practice of tracheostomy decannulation among medical staff in comprehensive and rehabilitation hospitals of different levels across the country and the factors considered when deciding to decannulate. Statistical methods used χ² test and one-way ANOVA. Results: A total of 570 questionnaires were collected from all over the country, with 463 valid questionnaires. The survey results showed that the most important factors in clinical practice to determine the decannulation of the tracheostomy tube were upper airway patency, cough effectiveness, level of consciousness and oxygenation. Before decannulation, 220 (47.50%) would choose to change to metal cannula, and 384 (82.90%) would routinely occlude the tube. 294 (63.50%) thought that re-intubation within 24 hours after decannulation of the tracheostomy tube was failure of decannulation. The decannulation failure rate was mostly 2%-5%. Conclusions: Upper airway patency, cough effectiveness, level of consciousness and oxygenation were important factors when considering decannulation. Reintubation within 24 hours of decannulation was defined as failure by the majority of respondents.


Subject(s)
Cough , Tracheostomy , Device Removal , Humans , Intubation, Intratracheal , Retrospective Studies , Surveys and Questionnaires , Tracheostomy/methods
2.
Materials (Basel) ; 12(11)2019 May 28.
Article in English | MEDLINE | ID: mdl-31142043

ABSTRACT

In this paper, low-energy proton irradiation experiments with different cumulative fluences were performed on samples of AISI 420 stainless steel that were either annealed or tempered at 600 or 700 °C. The effects of the cumulative proton irradiation fluence on the evolution of the microstructure of AISI 420 were studied by transmission electron microscopy (TEM). Scratch tests were performed using a Tribo Indenter nanomechanical tester, in order to investigate the effects of the cumulative fluence on the tribological properties of the AISI 420 stainless steel. The results indicate that the dislocation density of the microstructure near the surface of the AISI 420 stainless steel increases with higher cumulative proton irradiation fluences. Under the same load, the nanoscale friction coefficient and wear rate both decreased with increasing cumulative proton irradiation fluence. This indicates that the surface hardening effect induced by proton irradiation can diminish the nanoscale friction coefficient and wear rate.

3.
N Engl J Med ; 369(17): 1620-8, 2013 Oct 24.
Article in English | MEDLINE | ID: mdl-24152261

ABSTRACT

BACKGROUND: Dapsone is used in the treatment of infections and inflammatory diseases. The dapsone hypersensitivity syndrome, which is associated with a reported mortality of 9.9%, develops in about 0.5 to 3.6% of persons treated with the drug. Currently, no tests are available to predict the risk of the dapsone hypersensitivity syndrome. METHODS: We performed a genomewide association study involving 872 participants who had received dapsone as part of multidrug therapy for leprosy (39 participants with the dapsone hypersensitivity syndrome and 833 controls), using log-additive tests of single-nucleotide polymorphisms (SNPs) and imputed HLA molecules. For a replication analysis, we genotyped 24 SNPs in an additional 31 participants with the dapsone hypersensitivity syndrome and 1089 controls and performed next-generation sequencing for HLA-B and HLA-C typing at four-digit resolution in an independent series of 37 participants with the dapsone hypersensitivity syndrome and 201 controls. RESULTS: Genomewide association analysis showed that SNP rs2844573, located between the HLA-B and MICA loci, was significantly associated with the dapsone hypersensitivity syndrome among patients with leprosy (odds ratio, 6.18; P=3.84×10(-13)). HLA-B*13:01 was confirmed to be a risk factor for the dapsone hypersensitivity syndrome (odds ratio, 20.53; P=6.84×10(-25)). The presence of HLA-B*13:01 had a sensitivity of 85.5% and a specificity of 85.7% as a predictor of the dapsone hypersensitivity syndrome, and its absence was associated with a reduction in risk by a factor of 7 (from 1.4% to 0.2%). HLA-B*13:01 is present in about 2 to 20% of Chinese persons, 1.5% of Japanese persons, 1 to 12% of Indians, and 2 to 4% of Southeast Asians but is largely absent in Europeans and Africans. CONCLUSIONS: HLA-B*13:01 was associated with the development of the dapsone hypersensitivity syndrome among patients with leprosy. (Funded by the National Natural Science Foundation of China and others.).


Subject(s)
Dapsone/adverse effects , Drug Hypersensitivity/genetics , HLA-B Antigens/genetics , Leprostatic Agents/adverse effects , Leprosy/drug therapy , Adult , Dapsone/therapeutic use , Drug Therapy, Combination , Female , Genetic Predisposition to Disease , Genome-Wide Association Study , Genotype , Humans , Leprostatic Agents/therapeutic use , Leprosy/genetics , Male , Polymorphism, Single Nucleotide , Risk Factors , Sequence Analysis, DNA
SELECTION OF CITATIONS
SEARCH DETAIL
...